Investor Relations

Press Releases

Date Title and Summary View
Feb 12, 2015

Presentation Scheduled on Wednesday, February 25th, 2015 at 11:00 AM ET

Jan 20, 2015
PRINCETON, New Jersey , Jan. 20, 2015 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq:AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced today that it has entered into a definitive
Jan 06, 2015

Presentation Scheduled on Tuesday, January 20th, 2015 at 3:00 PM ET

Dec 22, 2014

Presentation Scheduled on Thursday, January 15th, 2015 at 9:30 AM Pacific Time

Dec 01, 2014

Data Demonstrate Skin Adhesion and Tolerability of Twirla(R) in a Large Population of Women Using the Patch for Up to 1 Year

Nov 18, 2014
PRINCETON, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced that John Hubbard, Ph.D., FCP has been appointed to the Company's Board of Directors, effective November 18, 2014. Dr. Hubbard will serve on Agile's Nominating and Corporate Governance
Nov 13, 2014

Company Continues to Progress Clinical Trial Site Activation and Subject Enrollment

Oct 01, 2014
PRINCETON, N.J., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) announced today that James P. Tursi, M.D. has been appointed to the Company's Board of Directors effective October 1, 2014. Dr. Tursi will serve on the Compensation Committee.
Sep 29, 2014
PRINCETON, N.J., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that the first patients have been dosed in its
Sep 22, 2014
PRINCETON, N.J., Sept. 22, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that Al Altomari, President and Chief Executive